LifeStance Health Group, Inc.
LFSTNASDAQHealthcare● Active
$7.39
$-0.02(-0.28%)
Market Cap$2.9B
P/E Ratio—
52W High$8.89
52W Low$3.74
LifeStance Health Group, Inc. (LFST) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
LFST · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
$0.04
Est. $0.01 · +300.0%
Revenue
$0.40B
Est. $0.39B · +4.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 9-Quarter EPS Beat Streak
LFST reports quarterly as a NASDAQ-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.37
Rev. $0.36B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.37
Rev. Est.$0.36B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.03 | — | — | — | $0.41B | — |
| ▲ Q2 FY2026 | May 7, 2026 | $0.01 | $0.04 | +300.0% | $0.40B | $0.39B | +4.1% |
| ▲ Q1 FY2026 | Feb 25, 2026 | -$0.00 | $0.03 | +3291.5% | $0.38B | $0.38B | +1.0% |
| ▲ Q4 FY2025 | Nov 6, 2025 | -$0.01 | $0.00 | +127.7% | $0.36B | $0.38B | -3.9% |
| ▲ Q3 FY2025 | Aug 7, 2025 | -$0.03 | -$0.01 | +66.7% | $0.35B | $0.36B | -3.6% |
| ▲ Q2 FY2025 | May 7, 2025 | -$0.04 | $0.00 | +104.6% | $0.33B | $0.35B | -4.5% |
| ▲ Q1 FY2025 | Feb 27, 2025 | -$0.04 | -$0.02 | +50.0% | $0.33B | $0.33B | -2.4% |
| ▲ Q4 FY2024 | Nov 7, 2024 | -$0.07 | -$0.02 | +71.4% | $0.31B | $0.31B | -0.4% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.03
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
$0.04
EPS Est.
$0.01
EPS Surpr.
+300.0%
Revenue
$0.40B
Q1 FY2026
Feb 25, 2026Beat
EPS Actual
$0.03
EPS Est.
-$0.00
EPS Surpr.
+3291.5%
Revenue
$0.38B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
$0.00
EPS Est.
-$0.01
EPS Surpr.
+127.7%
Revenue
$0.36B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
-$0.01
EPS Est.
-$0.03
EPS Surpr.
+66.7%
Revenue
$0.35B
Q2 FY2025
May 7, 2025Beat
EPS Actual
$0.00
EPS Est.
-$0.04
EPS Surpr.
+104.6%
Revenue
$0.33B
Q1 FY2025
Feb 27, 2025Beat
EPS Actual
-$0.02
EPS Est.
-$0.04
EPS Surpr.
+50.0%
Revenue
$0.33B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
-$0.02
EPS Est.
-$0.07
EPS Surpr.
+71.4%
Revenue
$0.31B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.12 | $0.13 | $0.13 | 1 |
| Q3 FY2028 | $0.11 | $0.11 | $0.12 | 1 |
| Q2 FY2028 | $0.11 | $0.12 | $0.12 | 1 |
| Q1 FY2028 | $0.11 | $0.11 | $0.11 | 1 |
| Q4 FY2027 | $0.07 | $0.07 | $0.08 | 1 |
| Q3 FY2027 | $0.07 | $0.07 | $0.07 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.5B | $0.6B | $0.6B | 2 |
| Q3 FY2028 | $0.5B | $0.5B | $0.6B | 2 |
| Q2 FY2028 | $0.5B | $0.5B | $0.5B | 2 |
| Q1 FY2028 | $0.5B | $0.5B | $0.5B | 2 |
| Q4 FY2027 | $0.5B | $0.5B | $0.5B | 3 |
| Q3 FY2027 | $0.5B | $0.5B | $0.5B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +300.0% | $7.36 | $8.85 | +20.24% |
| ▲ Q1 FY2026 | Feb 25, 2026 | +3291.5% | $7.14 | $7.41 | +3.78% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +127.7% | $4.81 | $6.25 | +29.94% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +66.7% | $3.90 | $3.86 | -1.03% |
| ▲ Q2 FY2025 | May 7, 2025 | +104.6% | $6.55 | $5.51 | -15.88% |
| ▲ Q1 FY2025 | Feb 27, 2025 | +50.0% | $7.51 | $7.74 | +3.06% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +71.4% | $7.13 | $7.68 | +7.71% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +14.3% | $5.51 | $5.93 | +7.62% |
Q2 FY2026+20.24%
Report Date
May 7, 2026
EPS Beat/Miss
+300.0%
Price Before
$7.36
Price After
$8.85
Q1 FY2026+3.78%
Report Date
Feb 25, 2026
EPS Beat/Miss
+3291.5%
Price Before
$7.14
Price After
$7.41
Q4 FY2025+29.94%
Report Date
Nov 6, 2025
EPS Beat/Miss
+127.7%
Price Before
$4.81
Price After
$6.25
Q3 FY2025-1.03%
Report Date
Aug 7, 2025
EPS Beat/Miss
+66.7%
Price Before
$3.90
Price After
$3.86
Q2 FY2025-15.88%
Report Date
May 7, 2025
EPS Beat/Miss
+104.6%
Price Before
$6.55
Price After
$5.51
Q1 FY2025+3.06%
Report Date
Feb 27, 2025
EPS Beat/Miss
+50.0%
Price Before
$7.51
Price After
$7.74
Q4 FY2024+7.71%
Report Date
Nov 7, 2024
EPS Beat/Miss
+71.4%
Price Before
$7.13
Price After
$7.68
Q3 FY2024+7.62%
Report Date
Aug 8, 2024
EPS Beat/Miss
+14.3%
Price Before
$5.51
Price After
$5.93
Avg Beat Reaction+6.93%
Beat Rate8 / 8 quarters
Largest Move+29.94% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: LFST ends December
LifeStance Health Group, Inc. (LFST) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $0.04 — beating the analyst consensus of $0.01 by +300.0%. LFST has beaten EPS estimates for 9 consecutive quarters. The next LFST earnings date is expected around September 1, 2026.
Each quarter, investors track LFST earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LFST revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
LFST's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
LFST earnings · 5 questionsLifeStance Health Group, Inc.'s next earnings report is expected around September 1, 2026. LFST typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LFST historically reports after market close (AMC).
LFST earnings datewhen is LFST earningsLFST next earnings datewhen does LFST report earningsLFST earnings calendar
▸ Source: FMP · LifeStance Health Group, Inc. SEC filings · US GAAP · LifeStance Health Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026